# Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

> **NCT06770023** · PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 4 (estimated)

## Conditions studied

- Lung Transplant
- Pulmonary Hypertension

## Interventions

- **DEVICE:** Protek Solo Transseptal Cannula

## Key facts

- **NCT ID:** NCT06770023
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-11
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06770023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06770023, "Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06770023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*